Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial.

Mukamal KJ, Clowry CM, Murray MM, Hendriks HF, Rimm EB, Sink KM, Adebamowo CA, Dragsted LO, Lapinski PS, Lazo M, Krystal JH.

Alcohol Clin Exp Res. 2016 Nov;40(11):2283-2291. doi: 10.1111/acer.13231. Review.

PMID:
27688006
2.

Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.

Sinn DH, Kang D, Chang Y, Ryu S, Gu S, Kim H, Seong D, Cho SJ, Yi BK, Park HD, Paik SW, Song YB, Lazo M, Lima JA, Guallar E, Cho J, Gwak GY.

Gut. 2016 Sep 6. pii: gutjnl-2016-311854. doi: 10.1136/gutjnl-2016-311854. [Epub ahead of print]

PMID:
27599521
3.

Obesity and Subtypes of Incident Cardiovascular Disease.

Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G, Nambi V, Ballantyne CM, Solomon SD, Selvin E, Folsom AR, Coresh J.

J Am Heart Assoc. 2016 Jul 28;5(8). pii: e003921. doi: 10.1161/JAHA.116.003921.

4.

Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.

Lazo M, Chen Y, McEvoy JW, Ndumele C, Konety S, Ballantyne CM, Sharrett AR, Selvin E.

Clin Chem. 2016 Sep;62(9):1202-10. doi: 10.1373/clinchem.2016.255778.

PMID:
27440513
5.

Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study.

Sanguankeo A, Lazo M, Upala S, Brancati FL, Bonekamp S, Pownall HJ, Balasubramanyam A, Clark JM; Fatty Liver Subgroup of the Look AHEAD Research Group..

Endocr Res. 2016 Jun 28:1-10. [Epub ahead of print]

PMID:
27351077
6.

Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience.

Lee CJ, Wood GC, Lazo M, Brown TT, Clark JM, Still C, Benotti P.

Obesity (Silver Spring). 2016 Jun;24(6):1342-8. doi: 10.1002/oby.21479.

7.

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.

Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, Pastor-Barriuso R, Ahn J, Kim CW, Rampal S, Cainzos-Achirica M, Zhao D, Chung EC, Shin H, Guallar E, Ryu S.

Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178.

PMID:
27185080
8.

Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.

Bilal U, Lau B, Lazo M, McCaul ME, Hutton HE, Sulkowski MS, Moore RD, Chander G.

AIDS Patient Care STDS. 2016 May;30(5):200-7. doi: 10.1089/apc.2016.0010.

PMID:
27158847
9.

Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.

Rubin J, Matsushita K, Lazo M, Ballantyne CM, Nambi V, Hoogeveen R, Sharrett AR, Blumenthal RS, Coresh J, Selvin E.

Clin Biochem. 2016 Jun;49(9):657-62. doi: 10.1016/j.clinbiochem.2016.01.024.

PMID:
26975902
10.

Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Seo SW, Gottesman RF, Clark JM, Hernaez R, Chang Y, Kim C, Ha KH, Guallar E, Lazo M.

Neurology. 2016 Mar 22;86(12):1136-42. doi: 10.1212/WNL.0000000000002498.

PMID:
26911638
11.

Effectiveness of an Activity Tracker- and Internet-Based Adaptive Walking Program for Adults: A Randomized Controlled Trial.

Poirier J, Bennett WL, Jerome GJ, Shah NG, Lazo M, Yeh HC, Clark JM, Cobb NK.

J Med Internet Res. 2016 Feb 9;18(2):e34. doi: 10.2196/jmir.5295.

12.

N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.

Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E.

Circulation. 2016 Feb 16;133(7):631-8. doi: 10.1161/CIRCULATIONAHA.115.017298.

PMID:
26746175
13.

Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.

Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E.

Am Heart J. 2015 Nov;170(5):961-7. doi: 10.1016/j.ahj.2015.08.008.

14.

Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.

Lazo M, Bilal U, Perez-Escamilla R.

Curr Diab Rep. 2015 Dec;15(12):116. doi: 10.1007/s11892-015-0674-6. Review.

PMID:
26468154
15.

Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad.

Ramtahal R, Khan C, Maharaj-Khan K, Nallamothu S, Hinds A, Dhanoo A, Yeh HC, Hill-Briggs F, Lazo M.

J Epidemiol Glob Health. 2015 Dec;5(4 Suppl 1):S35-43. doi: 10.1016/j.jegh.2015.05.003.

16.

Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.

McEvoy JW, Lazo M, Chen Y, Shen L, Nambi V, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E.

Int J Cardiol. 2015;187:651-7. doi: 10.1016/j.ijcard.2015.03.436.

17.

Association between serum uric acid and nonalcoholic fatty liver disease in the US population.

Shih MH, Lazo M, Liu SH, Bonekamp S, Hernaez R, Clark JM.

J Formos Med Assoc. 2015 Apr;114(4):314-20. doi: 10.1016/j.jfma.2012.11.014.

18.

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.

Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM, Selvin E.

Am J Hypertens. 2015 Oct;28(10):1262-6. doi: 10.1093/ajh/hpv026.

19.

Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, Vaidya D.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1686-93.e2. doi: 10.1016/j.cgh.2014.12.033.

20.

Obesity, subclinical myocardial injury, and incident heart failure.

Ndumele CE, Coresh J, Lazo M, Hoogeveen RC, Blumenthal RS, Folsom AR, Selvin E, Ballantyne CM, Nambi V.

JACC Heart Fail. 2014 Dec;2(6):600-7. doi: 10.1016/j.jchf.2014.05.017.

Items per page

Supplemental Content

Loading ...
Support Center